Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02339116
Title Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC (TRIBE2)
Acronym TRIBE2
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements No
Sponsors Gruppo Oncologico del Nord-Ovest
Age Groups: senior | adult
Covered Countries ITA

No variant requirements are available.